Calidi Biotherapeutics (CLDI) Shares Outstanding (2021 - 2025)

Calidi Biotherapeutics has reported Shares Outstanding for 5 years, with the latest figure at $7.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 317.15% year-over-year to $7.2 million; the trailing twelve-month figure through Dec 2025 stood at $7.2 million (up 317.15% YoY), and the FY2025 full-year result was $7.2 million, up 317.15% from the prior year.
• Shares Outstanding for Q4 2025 stood at $7.2 million, up from $6.9 million in the prior quarter.
• The five-year high for Shares Outstanding was $8.6 million in Q2 2022, with the low at $105928.0 in Q2 2023.
• Average Shares Outstanding over 5 years is $3.2 million, with a median of $1.7 million recorded in 2024.
• Year-over-year, Shares Outstanding slumped 95.85% in 2022 and jumped 790.11% in 2025.
• Tracing CLDI's Shares Outstanding over 5 years: stood at $4.3 million in 2021, then tumbled by 95.85% to $179665.0 in 2022, then jumped by 64.76% to $296019.0 in 2023, then jumped by 484.44% to $1.7 million in 2024, then jumped by 317.15% to $7.2 million in 2025.
• The last three Shares Outstanding figures came in at $7.2 million (Q4 2025), $6.9 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.

Peer Comparison